Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer

As this is a Send there is no summary

WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth

IntroductionIn breast cancer deregulation of the WNT signaling system occurs by autocrine mechanisms. WNT ligands and Frizzled (FZD) receptors are coexpressed in substantial breast tumors and cancer cell lines. Moreover, multifold breast tumors grandstand play hypermethylation of secreted Frizzled-related protein 1 (sFRP1)' s promoter region, causing low word of this WNT antagonist. We obtain previously shown that the WNT course influences proliferation of breast cancer cell lines via activation of canonical signaling and epidermal augmentation factor receptor (EGFR) transactivation, and that interference with WNT signaling reduces proliferation. Here we study the role of WNT signaling in breast tumor cell migration and on xenograft outgrowth.

Anti-VEGF Therapy as Antiangiogenic Therapy: Clouds on the Horizon?

Antiangiogenic therapies have demonstrated their value in the setting of advanced cancer, and are being explored for micrometastatic disease. Modern preclinical studies suggest that adjuvant anti-VEGF therapies may escalation the risk of metastasis. How concerning are these preclinical studies, and should they affect our willingness to inquire into anti-VEGF therapy in the adjuvant setting?

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

IntroductionThe stop of this glance at was to describe breast tumor subtypes by popular breast cancer risk factors and to conclude correlates of subtypes using baseline data from two pooled prospective breast cancer studies within a blimp health concervation organization. Methods: Tumor info on 2544 invasive breast cancer cases subtyped by estrogen receptor, progesterone receptor, and human epidermal boost stuff receptor 2 (Her2) status were obtained (1868 luminal A tumors, 294 luminal B tumors, 288 triple-negative tumors and 94 Her2-overexpressing tumors). Demographic, reproductive and lifestyle dossier was collected either in workman or by mailed questionnaires.

Links between TGF-beta and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity.

In a new subject of BCR, the Serra lab describes a legend mechanism of TGF-beta tumor suppression [1]. Previously, the authors discovered that stromal TGF-beta signaled nailed down Wnt5a to restrain pubertal ductal elongation and branching. Here, they show that inhibition of stromal TGF-beta signaling or Wnt5a loss leads to increased beta-catenin transcriptional motion and reduced latency in mammary tumor models, with tumors displaying a higher proportion of progenitor cell markers. These findings blab a account intersection of two tumor suppressors with a potent oncogenic plan and spotlight the need for very recite on the role of canonical Wnt signaling in breast cancer susceptibility and subtype.

PI-3 kinase activity is necessary for ERK1 2 induced disruption of mammary epithelial architecture

IntroductionEpithelial tumors, including breast cancer, are being identified and treated at earlier stages of tumor transaction because of technological advances in screening and detection methods. It is possible that early stage epithelial tumors, such as mammary ductal carcinoma in situ (DCIS), testament be amenable to new and more efficacious diagnostic tests and forms of therapy. However, our resident discerning of the underlying molecular mechanisms of early event epithelial tumor growth has hampered the development of contemporary forms treatment and preventative therapy. Methods: The Raf-MEK1/2-ERK1/2 MAP kinase module is activated by stimuli complicit in mammary neoplastic progression.

A constant risk of familial breast cancer? A population-based family study

IntroductionThe incidence of breast cancer in the unaffected breast of women with previous breast malignancy remains fixed after basic diagnosis. We investigated if there is a similar replica in the incidence in first degree relatives of breast cancer patients. We studied the risk of breast cancer in mothers at ages older than their daughter' s lifetime at diagnosis. Methods: We analysed a Swedish population-based cohort with imperforate family links and calculated incidence rates of breast cancer in mothers of 48, 259 daughters diagnosed with breast cancer. Results: The risk of breast cancer in mothers of breast cancer patients is elevated compared to the background population at all ages.

The spatial distribution of radiodense breast tissue: a longitudinal study

IntroductionMammographic breast density is one of the strongest known markers of susceptibility to breast cancer. To date trial into density has relied on a single measure (e.g. percent density) summarizing the guideline commensurate of density for the whole breast, with no consideration of how the radiodense tissue may be distributed. This glance at aims to investigate the spatial distribution of density within the breast using 493 mammographic images from a illustration of 165 pre-menopausal women (~3 medio-lateral oblique views per woman). Methods: Each breast image was divided into 48 regions and percent density (PD) for the full breast (overall PD) and for everyone one of its regions (regional PD) was estimated.

Estrogen regulation of apoptosis- how can one hormone stimulate and inhibit?

The link between estrogen and the elaborating and proliferation of breast cancer is fine documented. Estrogen stimulates growth and inhibits apoptosis through oestrogen receptor (ER)-mediated mechanisms in many cell types. Interestingly, there is strong evidence that estrogen induces apoptosis in breast cancer and other cell types. Forty age ago, before the course of tamoxifen, high-dose estrogen was used to induce tumour regression of hormone-dependent breast cancer in postmenopausal women. While the mechanism(s) by which estrogen induces apoptosis was not completely known, recent evidence from our laboratory and others demonstrate the involvement of the extrinsic (Fas/FasL) and the intrinsic (mitochondria) pathways in this process.

Immunohistochemical characterization of subtypes of male breast carcinoma

IntroductionMale breast cancer accounts for on all sides of 1% of all breast cancer cases on the contrary has a rising incidence in recent years. This read is aimed to classify the molecular subtypes of adult breast cancers based on the signal profile of immunomarkers and to evaluate their association with clinicopathological features and expression patterns of epidermal growth factor receptor (EGFR) and nuclear antecedent kappa-B (NF-kB). Methods: A total of 42 cases of workman breast carcinoma were examined retrospectively using immunostains for estrogen receptor (ER), progesterone receptor (PR), cytokeratin 5/6 (CK5/6), EGFR, and NF-kB. HER2 expression was evaluated by immunostaining and confirmed by fluorescent in situ hybridization (FISH).